OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/30/2025
Back to search
Official data from USPTO
ACTINEER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079397582Class
1, 5, 10, 42, 44
Filing
79397582
Registration
7741628
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
04/03/2026
Trademark type
Combined
Nice classes
1, 5, 10, 42, 44
Filing date
02/08/2024
Registration date
04/01/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/01/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
DE
Examiner
FRENCH, CURTIS W
Law office
M60
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the term ACTINEER is stylized font with a design of a stylized ribbon to the left of the wording.
Holders and representatives
Holders
I. S. (pessoa física)
Representatives
Kari Moyer-Henry Lewis Kohn & Walker LLP
Technical classification
Nice Classes
Class 1Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical substanceschemical materials and chemical preparations for use in the manufacture of medical products; chemical substanceschemical materials and chemical preparations for use in the manufacture of radiopharmaceutical products; chemical raw materialsin particular actinium-225 radiochemicalfor the formulation of radiopharmaceutical products; chemical raw materialsin particular bismuth-213for the formulation of radiopharmaceutical products
Class 5
Radiopharmaceutical diagnostic preparations for medical purposes; radiopharmaceutical diagnostic preparations for pharmaceutical purposes; radiopharmaceutical therapeutic preparations for medical purposes; radiopharmaceutical therapeutic preparations for pharmaceutical purposesin particular radiopharmaceutical preparations for endo-radionuclide therapybrachytherapypositron emission tomographysingle photon emission computed tomographytarget radionuclide therapy and peptide receptor radionuclide therapy; radiopharmaceutical preparationsin particular actinium-containing radiopharmaceutical products in GMP quality; radiopharmaceutical preparationsin particular bismuth-containing radiopharmaceutical products in GMP quality; radiopharmaceutical preparations for use in oncologyin particular radiopharmaceuticals containing radioisotopesin particular actinium-225; radiopharmaceutical preparations for use in oncologyin particular radiopharmaceuticals containing radioisotopesin particular bismuth-213; radiopharmaceuticals containing medical radioisotopes with longer half-livesin particular actinium-225 for the treatment of tumour diseases; radiopharmaceuticals containing medical radioisotopes with longer half-livesin particular bismuth-213 for the treatment of tumour diseases; target radiopharmaceuticals containing a target moleculein particular peptidedepending on the indicationa medical radioactive isotope; target radiopharmaceuticals containing a target moleculein particular an antibody dependingon the indicationa medical radioactive isotope; radiopharmaceuticals containing actinium-225 and its complexes; radiopharmaceuticals containing bismuth-213 and its complexes
Class 10
Medical instrumentsapparatus and containers for the production of radiopharmaceutical preparationsnamely sample preparation devices automatically or manually operated in particular for the production of actinium-225 in GMP quality; medical instrumentsapparatus and containers for the production of radiopharmaceutical preparationsnamely sample preparation devices automatically or manually operated in particular for the production of bismuth-213 in GMP quality; controlregulation and measuring apparatus as parts of medical instrumentsapparatus and containersin particular devices containing fluidic processing components as valvessmall vessels (5-500 ml) and purification columns for the production of a radiotherapeutic or radiodiagnostic substancein particular for the production of actinium-225 in GMP quality; controlregulation and measuring apparatus as parts of medical instrumentsapparatus and containers included in this classin particular devices containing fluidic processing components as valvessmall vessels (5-500 ml) and purification columns for the production of a radiotherapeutic or radiodiagnostic substancein particular for the production of bismuth-213 in GMP quality; radionuclide generator for radiopharmaceutical purpose
Class 42
Scientific and technological services and research relating to the use of actinium-225in particular medical and pharmacological research services relating to the use of actinium-225; scientific and technological services and research relating to the use of bismuth-213in particular medical and pharmacological research services relating to the use of bismuth-213; scientific and technological services and research relating to the use of other alpha emittersin particular medical and pharmacological research services relating to the use of other alpha emitters
Class 44
Medical servicesin particular medical services relating to radiotherapeutic and radiodiagnostic oncologycardiologyangiologyneuroradiologynuclear medicine and brachytherapiesnamely intercavitaryinterstitial and intravascular brachytherapyradionuclide labellingPET and SPECT scanning and radionuclide therapypeptide receptor radionuclide therapypersonal nuclear medicine and precision oncology; medical services for theranostics in the field of precision oncology
Publications
History of USPTO decisions and trademark events.
30 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/12/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/12/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/31/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/15/2025
FIMP
FINAL DISPOSITION PROCESSED
10/14/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/02/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/01/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
04/01/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/11/2025
PUBO
PUBLISHED FOR OPPOSITION
02/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/05/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/21/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/30/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/30/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/30/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/18/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/18/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/18/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/18/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/18/2024
RFNT
REFUSAL PROCESSED BY IB
09/30/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/11/2024
RFRR
REFUSAL PROCESSED BY MPU
09/11/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/09/2024
CNRT
NON-FINAL ACTION WRITTEN
09/08/2024
DOCK
ASSIGNED TO EXAMINER
09/02/2024
MAFR
APPLICATION FILING RECEIPT MAILED
06/20/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/20/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/13/2024
Continuous trademark protection
Get notified about every new filing that threatens ACTINEER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.